Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Implant Sciences Cp (IMSC)

Implant Sciences Cp (IMSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Implant Sciences Cp 500 Research Drive Unit 3 Wilmington MA 01887

www.implantsciences.com P: 978-752-1700

Description:

Implant Sciences Corporation a developer and manufacturer of products for the national security, semiconductor and medical industries, uses its patented ion beam technology to develop, manufacture and sell products through its primary business units: (i) trace explosives detection systems for homeland security, defense, and other security related applications and (ii) state of the art services for the medical and semiconductor industries. The Company has developed and begun shipments of handheld, portable trace explosive detection systems to a growing number of locations around the world and domestically. Building on several core technological capabilities, the Company is working on the development of several next generation trace explosives detection systems. The Company believes its strong background in ion beam technology addresses many important security needs in aviation, cargo, transportation, and other related elements of the government and commercial infrastructure.

Key Statistics

Overview:

Market Capitalization, $K 8,920
Shares Outstanding, K 79,030
Annual Sales, $ 12,990 K
Annual Net Income, $ -21,540 K
60-Month Beta 0.63
% of Insider Shareholders 16.70%
% of Institutional Shareholders 0.03%

Growth:

1-Year Return -76.19%
3-Year Return -67.41%
5-Year Return -19.30%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 10/13/16
Earnings Per Share ttm -0.10
EPS Growth vs. Prev Qtr -25.00%
EPS Growth vs. Prev Year 37.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IMSC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -165.82%
Debt/Equity 0.00
Price/Sales 0.25
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar